ScholarLens Back to search
2007•Unpublished venueRequires access

Effectiveness of amiodarone in treating AMI patients and non-AMI complicated with paroxysmal atrial fibrillation

Ling Zhang

Open publisher page 0 citations

Abstract

Objective:To evaluate effectiveness of intravenous amiodarone in treating patients with or without acute myocardial infarction(AMI)complicated with paroxysmal atrial fibrillation(PAF).Methods:The 23 patients with AMI and 20 patients without AMI complicated PAF were given load dosage of amiodarone 5 mg/kg,then maintenance dosage of 10~20/kg·d.Maximum dosage was less than 2 200 mg during 24 h.Results:The cardioversion rate of PAF in AMI group was 100%,in control group was 70%,there was statistical difference between two groups(P0.05).For cardioversion time,it of AMI group was(2063±138)min,there was no statistical difference between two groups(P0.05).Conclusion:Treating AMI or non-AMI patients complicated with paroxysmal fibrillation by using amiodarone has much higher cardioversion rate and is safe.

About this research paper

What this paper is about

Objective:To evaluate effectiveness of intravenous amiodarone in treating patients with or without acute myocardial infarction(AMI)complicated with paroxysmal atrial fibrillation(PAF).Methods:The 23 patients with AMI and 20 patients without AMI complicated PAF were given load dosage of amiodarone 5 mg/kg,then maintenance dosage of 10~20/kg·d.Maximum dosage was less than 2 200 mg during 24 h.Results:The cardioversion rate of PAF in AMI group was 100%,in control group was 70%,there was statistical difference between two groups(P0.05).For cardioversion time,it of AMI group was(2063±138)min,there was no statistical difference between two groups(P0.05).Conclusion:Treating AMI or non-AMI patients complicated with paroxysmal fibrillation by using amiodarone has much higher cardioversion rate and is safe.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate effectiveness of intravenous amiodarone in treating patients with or without acute myocardial infarction(AMI)complicated with paroxysmal atrial fibrillation(PAF).Methods:The 23 patients with AMI and 20 patients without AMI complicated PAF were given load dosage of amiodarone 5 mg/kg,then maintenance dosage of 10~20/kg·d.Maximum dosage was less than 2 200 mg during 24 h.Results:The cardioversion rate of PAF in AMI group was 100%,in control group was 70%,there was statistical difference between two groups(P0.05).For cardioversion time,it of AMI group was(2063±138)min,there was no statistical difference between two groups(P0.05).Conclusion:Treating AMI or non-AMI patients complicated with paroxysmal fibrillation by using amiodarone has much higher cardioversion rate and is safe.

Key concepts: Medicine, Amiodarone, Cardioversion, Cardiology, Internal medicine, Atrial fibrillation, Myocardial infarction, Paroxysmal atrial fibrillation

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effectiveness of amiodarone in treating AMI patients and non-AMI complicated with paroxysmal atrial fibrillation — Research Paper | ScholarLens